Literature DB >> 31426856

Prolotherapy for knee osteoarthritis using hypertonic dextrose vs other interventional treatments: systematic review of clinical trials.

Pedro Iván Arias-Vázquez1, Carlos Alfonso Tovilla-Zárate2, Blanca Gabriela Legorreta-Ramírez3, Wajid Burad Fonz4, Dory Magaña-Ricardez1, Thelma Beatriz González-Castro5, Isela Esther Juárez-Rojop5, María Lilia López-Narváez6.   

Abstract

BACKGROUND: To evaluate the efficacy and safety of prolotherapy with hypertonic dextrose in patients with knee osteoarthritis. A systematic search was performed in electronic databases including PUBMED, SCIELO, DIALNET and Google Scholar. MAIN BODY: We searched for randomized clinical trials that evaluated therapeutic interventions in patients with knee osteoarthritis. These trials compared the effect of intra-articular and / or extra-articular infiltrations of hypertonic dextrose vs the effect of intra-articular and / or extra-articular infiltrations of other substances or some interventional procedure application, via assessing pain, physical function and secondary effects and / or adverse reactions. Ten randomized clinical trials were included in this systematic review, the total sample size comprised 328 patients treated with hypertonic dextrose (prolotherapy) vs 348 controls treated with other infiltrations such as local anesthetics, hyaluronic acid, ozone, platelet-rich plasma or interventional procedures like radiofrequency.
CONCLUSIONS: In terms of pain reduction and function improvement, prolotherapy with hypertonic dextrose was more effective than infiltrations with local anesthetics, as effective as infiltrations with hyaluronic acid, ozone or radiofrequency and less effective than PRP and erythropoietin, with beneficial effect in the short, medium and long term. In addition, no side effects or serious adverse reactions were reported in patients treated with hypertonic dextrose. Although HDP seems to be a promising interventional treatment for knee OA, more studies with better methodological quality and low risk of bias are needed to confirm the efficacy and safety of this intervention.

Entities:  

Keywords:  Hypertonic dextrose; Knee; Osteoarthritis; Prolotherapy

Mesh:

Substances:

Year:  2019        PMID: 31426856     DOI: 10.1186/s42358-019-0083-7

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  6 in total

Review 1.  Meta-analysis of clinical trials focusing on hypertonic dextrose prolotherapy (HDP) for knee osteoarthritis.

Authors:  Jun Wang; Jie Liang; Jin Yao; Hai Xin Song; Xiao Tian Yang; Fang Chao Wu; Ye Ye; Jian Hua Li; Tao Wu
Journal:  Aging Clin Exp Res       Date:  2021-08-27       Impact factor: 3.636

2.  A Comprehensive Update of Prolotherapy in the Management of Osteoarthritis of the Knee.

Authors:  Alex Tang Zhao; Cassidy J Caballero; Linh T Nguyen; Hunter C Vienne; Christopher Lee; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 3.  Joint interventions in osteoarthritis.

Authors:  Michel D Crema; Ali Guermazi; Frank W Roemer
Journal:  Skeletal Radiol       Date:  2022-08-18       Impact factor: 2.128

4.  Combine Approach of Proximal Fibula Osteotomy (PFO) Followed by Intra-Articular Dextrose Prolotherapy in Severe Medial Knee Osteoarthritis.

Authors:  Alif Noeriyanto Rahman; Herry Herman; Eri Kriswanto; Ahmad Faried; Mochammad Kamal Nasser
Journal:  J Pain Res       Date:  2022-07-15       Impact factor: 2.832

Review 5.  Comparing dextrose prolotherapy with other substances in knee osteoarthritis pain relief: A systematic review.

Authors:  Vitor Santos Cortez; Walter Augusto Moraes; João Victor Taba; Alberto Condi; Milena Oliveira Suzuki; Fernanda Sayuri do Nascimento; Leonardo Zumerkorn Pipek; Vitoria Carneiro de Mattos; Matheus Belloni Torsani; Alberto Meyer; Wu Tu Hsing; Leandro Ryuchi Iuamoto
Journal:  Clinics (Sao Paulo)       Date:  2022-05-17       Impact factor: 2.898

Review 6.  Dextrose prolotherapy in knee osteoarthritis: A systematic review and meta-analysis.

Authors:  Tze Chao Wee; Edmund Jin Rui Neo; Yeow Leng Tan
Journal:  J Clin Orthop Trauma       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.